Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sidderb
    Member
    • Aug 2011
    • 14

    #1

    Interpreting 5'/3' bias

    Hi All,
    We have 100bp PE RNAseq data generated on a HiSeq2000 from a library prepped with the Nugen Ovation v2 kit. The samples are from human and rat, with the human samples of lesser quality (RIN<7) whilst the rat are fine. Reads were aligned with bowtie using default options.

    Using RSeQC we see the following profiles of counts across transcripts:

    Click image for larger version

Name:	rseqc_gene_coverage.png
Views:	1
Size:	142.2 KB
ID:	307786

    Does anyone have any ideas on how to interpret this? I was expecting a possible 3' bias from the degraded(?) samples and/or the library prep, but wasn't expecting to see both a 3' and 5' bias...

    What would you do on the back of this, anything?

    Thanks.
    @sidderb
  • sidderb
    Member
    • Aug 2011
    • 14

    #2
    Can anyone help?
    @sidderb

    Comment

    • aparna
      Member
      • Feb 2009
      • 17

      #3
      What %of reads were mapped?

      Comment

      • sidderb
        Member
        • Aug 2011
        • 14

        #4
        ~60% in all samples
        @sidderb

        Comment

        • scooter
          Member
          • Feb 2010
          • 29

          #5
          I suspect the library prep method was not a stranded protocol. This would result in ~1/2 of the PE data being in one orientation (i.e. reads are 5'-3' relative to transcript) and the other 1/2 being in the opposite orientation (3'-5'). I have heard the ovation kit has a 3' bias, so in your case the 5' bias is simply the reads in the antisense direction.

          I am not sure this is correct, just a hunch.

          Comment

          • aparna
            Member
            • Feb 2009
            • 17

            #6
            I would suspect at the library prep phase as scooter.But since the data is out - I would try to improve mapping by using other aligners.
            Bowtie is good for RNA seq with end to end mapping (sensitive mode) but in that way it is more stringent and I personally dont want to use it as my first aligner of choice.
            If you like Bowtie's performance - I would suggest you to use Bowtie2 - which allows gapped alignment.
            I would also suggest you to use bwa just to have another comparison of mapping.

            By the way have you done pre-mapping QC?Did you had to trim the reads?
            what were you mapping to?

            -Aparna

            Comment

            • pmiguel
              Senior Member
              • Aug 2008
              • 2328

              #7
              Originally posted by sidderb View Post
              Hi All,
              We have 100bp PE RNAseq data generated on a HiSeq2000 from a library prepped with the Nugen Ovation v2 kit. The samples are from human and rat, with the human samples of lesser quality (RIN<7) whilst the rat are fine. Reads were aligned with bowtie using default options.

              Using RSeQC we see the following profiles of counts across transcripts:

              [ATTACH]1333[/ATTACH]

              Does anyone have any ideas on how to interpret this? I was expecting a possible 3' bias from the degraded(?) samples and/or the library prep, but wasn't expecting to see both a 3' and 5' bias...

              What would you do on the back of this, anything?

              Thanks.
              Doesn't this kit do ligations to the end (or extensions from the end)? If so, it might be the result of a failure of the RNA in the human sample to fragment prior to adding adapters.

              If you had provided a link to the protocol I might have read it and been able to give you a more targeted answer.

              --
              Phillip

              Comment

              • liguow
                Member
                • Apr 2009
                • 12

                #8
                Originally posted by sidderb View Post
                Hi All,
                We have 100bp PE RNAseq data generated on a HiSeq2000 from a library prepped with the Nugen Ovation v2 kit. The samples are from human and rat, with the human samples of lesser quality (RIN<7) whilst the rat are fine. Reads were aligned with bowtie using default options.

                Using RSeQC we see the following profiles of counts across transcripts:

                [ATTACH]1333[/ATTACH]

                Does anyone have any ideas on how to interpret this? I was expecting a possible 3' bias from the degraded(?) samples and/or the library prep, but wasn't expecting to see both a 3' and 5' bias...

                What would you do on the back of this, anything?

                Thanks.
                Maybe you can try "read_distribution.py" in RSeQC package to reaffirm this observation. You are expecting to see higher coverage in both 3'UTR and 5'UTR than the internal CDS exons.

                Comment

                • pbluescript
                  Senior Member
                  • Nov 2009
                  • 224

                  #9
                  Did you map to a genome or transcriptome?
                  If you mapped to a genome, you should try mapping with something specifically made for RNA-Seq data like Tophat or STAR so that you can map reads split across an exon-exon junction. I have noticed a larger 3'UTR bias sometimes when I map RNA-Seq data with Bowtie or BWA to a genome. The 3'UTR is often the longest part of a gene and you'll get more reads mapping there since there are fewer split reads.

                  Comment

                  • kopi-o
                    Senior Member
                    • Feb 2008
                    • 319

                    #10
                    I have seen a similar large 3' bias in rRNA-depleted libraries, but not poly-A selected ones. I don't know how to explain it, though.

                    Comment

                    Latest Articles

                    Collapse

                    • SEQadmin2
                      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                      by SEQadmin2



                      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                      Despite this, “CRISPR helped turn genome editing from a specialized technique into
                      ...
                      07-31-2026, 11:01 AM
                    • SEQadmin2
                      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                      by SEQadmin2


                      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                      The systematic characterization of the human proteome has
                      ...
                      07-20-2026, 11:48 AM
                    • SEQadmin2
                      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                      by SEQadmin2



                      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                      ...
                      07-09-2026, 11:10 AM

                    ad_right_rmr

                    Collapse

                    News

                    Collapse

                    Topics Statistics Last Post
                    Started by SEQadmin2, 08-06-2026, 07:41 AM
                    0 responses
                    13 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 08-03-2026, 10:13 AM
                    0 responses
                    31 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-31-2026, 02:55 AM
                    0 responses
                    40 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-24-2026, 12:17 PM
                    0 responses
                    26 views
                    0 reactions
                    Last Post SEQadmin2  
                    Working...